Wellington Management Group LLP acquired a new stake in Versigent (NYSE:VGNT - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 22,386 shares of the company's stock, valued at approximately $940,000.
Versigent Stock Up 1.2%
VGNT opened at $46.98 on Friday. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40. Versigent has a 52 week low of $26.34 and a 52 week high of $50.88. The stock's 50 day moving average price is $44.42. The firm has a market capitalization of $3.33 billion and a price-to-earnings ratio of 24.47.
Versigent (NYSE:VGNT - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $1.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.58 by $0.34. The business had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.29 billion. Equities analysts expect that Versigent will post 7.23 EPS for the current fiscal year.
Versigent Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Friday, September 4th will be paid a dividend of $0.13 per share. The ex-dividend date is Friday, September 4th. This represents a $0.52 dividend on an annualized basis and a yield of 1.1%.
Insider Transactions at Versigent
In other Versigent news, Director Kevin Clark sold 74,130 shares of Versigent stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $45.67, for a total value of $3,385,517.10. Following the transaction, the director directly owned 124,849 shares in the company, valued at approximately $5,701,853.83. The trade was a 37.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on VGNT. Zacks Research cut Versigent from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 5th. Royal Bank Of Canada raised shares of Versigent from a "sector perform" rating to an "outperform" rating and raised their price objective for the stock from $41.00 to $52.00 in a report on Wednesday, August 5th. Argus boosted their price objective on shares of Versigent from $50.00 to $54.00 and gave the stock a "buy" rating in a research report on Thursday, August 13th. Evercore restated an "outperform" rating and issued a $65.00 target price on shares of Versigent in a report on Monday, August 10th. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and issued a $59.00 target price on shares of Versigent in a research report on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $54.00.
Get Our Latest Stock Report on Versigent
About Versigent
(
Free Report)
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Featured Stories
Want to see what other hedge funds are holding VGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Versigent (NYSE:VGNT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Versigent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.
While Versigent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.